{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:03:18Z","timestamp":1783479798863,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intra-articular tranexamic acid (TXA) as an adjunct to intravenous TXA was reported to decrease perioperative blood loss during unilateral total knee arthroplasty (TKA). However, there have been no randomized controlled trials comparing intravenous versus combined intravenous and intra-articular TXA administration in patients undergoing simultaneous bilateral TKA.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We randomly assigned 77 patients with 154 involved knees undergoing simultaneous bilateral TKA to the intravenous TXA group (intra-articular placebo for each knee) or combined TXA group (1000\u2009mg of intra-articular TXA for each knee) with 1:1 treatment allocation. In both groups, 1000\u2009mg of TXA was given intravenously twice, just before surgery and 6\u2009h after the initial administration. Other perioperative medications, surgical procedures, and blood management strategies were the same for all patients. The primary outcome was perioperative blood loss calculated from blood volume and change in hemoglobin from preoperative to postoperative day 3.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Intention-to-treat analysis showed no statistically significant differences in perioperative blood loss until postoperative day 3 (1067\u2009\u00b1\u2009403\u2009mL in the intravenous TXA group vs. 997\u2009\u00b1\u2009345\u2009mL in the combined TXA group [95% CI, \u2212\u2009240 to 100\u2009mL], <jats:italic>P<\/jats:italic>\u2009=\u20090.42). No patients required allogenic blood transfusion. The incidence of thrombotic events did not differ between groups (12% in the intravenous TXA group vs. 9% in the combined TXA group; <jats:italic>P<\/jats:italic>\u2009=\u20090.73).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The addition of intra-articular TXA did not reduce perioperative blood loss in patients undergoing simultaneous bilateral TKA compared with placebo.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>University Hospital Medical Information Network <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000030035\">UMIN000026137<\/jats:ext-link>. Registered 14 February 2017.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-019-2890-8","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:12:14Z","timestamp":1571703134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Intra-articular tranexamic acid as an adjunct to intravenous tranexamic acid for simultaneous bilateral total knee arthroplasty: a randomized double-blind, placebo-controlled trial"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1186-5232","authenticated-orcid":false,"given":"Sachiyuki","family":"Tsukada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kurosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuyuki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Yonekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Hirasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"2890_CR1","doi-asserted-by":"publisher","first-page":"g4829","DOI":"10.1136\/bmj.g4829","volume":"349","author":"J Poeran","year":"2014","unstructured":"Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349:g4829.","journal-title":"BMJ"},{"key":"2890_CR2","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1016\/j.arth.2018.04.043","volume":"33","author":"YA Fillingham","year":"2018","unstructured":"Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Shores P, Mullen K, Bini SA, Clarke HD, Schemitsch E, Johnson RL, Memtsoudis SG, Sayeed SA, Sah AP, Della Valle CJ. The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis. J Arthroplasty. 2018;33:3090\u20133098.e1.","journal-title":"J Arthroplasty"},{"key":"2890_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3928\/01477447-20160301-05","volume":"39","author":"ZX Lin","year":"2016","unstructured":"Lin ZX, Woolf SK. Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics. 2016;39:119\u201330.","journal-title":"Orthopedics"},{"key":"2890_CR4","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2106\/JBJS.N.00060","volume":"96","author":"E Gomez-Barrena","year":"2014","unstructured":"Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, P\u00e9rez-Chrzanowska H, Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am. 2014;96:1937\u201344.","journal-title":"J Bone Joint Surg Am"},{"key":"2890_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2106\/JBJS.15.00810","volume":"98","author":"CS Nielsen","year":"2016","unstructured":"Nielsen CS, Jans \u00d8, \u00d8rsnes T, Foss NB, Troelsen A, Husted H. Combined intra-articular and intravenous tranexamic acid reduces blood loss in total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am. 2016;98:835\u201341.","journal-title":"J Bone Joint Surg Am"},{"key":"2890_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.arth.2015.09.029","volume":"31","author":"NP Jain","year":"2016","unstructured":"Jain NP, Nisthane PP, Shah NA. Combined administration of systemic and topical tranexamic acid for total knee arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplast. 2016;31:542\u20137.","journal-title":"J Arthroplast"},{"key":"2890_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.arth.2016.06.052","volume":"32","author":"EK Song","year":"2017","unstructured":"Song EK, Seon JK, Prakash J, Seol YJ, Park YJ, Jin C. Combined administration of IV and topical tranexamic acid is not superior to either individually in primary navigated TKA. J Arthroplast. 2017;32:37\u201342.","journal-title":"J Arthroplast"},{"key":"2890_CR8","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.arth.2014.05.026","volume":"29","author":"Z Huang","year":"2014","unstructured":"Huang Z, Ma J, Shen B, Pei F. Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplast. 2014;29:2342\u20136.","journal-title":"J Arthroplast"},{"key":"2890_CR9","first-page":"94","volume":"309","author":"JJ Jankiewicz","year":"1994","unstructured":"Jankiewicz JJ, Sculco TP, Ranawat CS, Behr C, Tarrentino S. One-stage versus 2-stage bilateral total knee arthroplasty. Clin Orthop Relat Res. 1994;309:94\u2013101.","journal-title":"Clin Orthop Relat Res"},{"key":"2890_CR10","doi-asserted-by":"publisher","first-page":"e0002","DOI":"10.2106\/JBJS.OA.17.00002","volume":"2","author":"S Tsukada","year":"2017","unstructured":"Tsukada S, Wakui M. Combined intravenous and intra-articular tranexamic acid in simultaneous bilateral total knee arthroplasty without tourniquet use. JBJS Open Access. 2017;2:e0002.","journal-title":"JBJS Open Access"},{"key":"2890_CR11","doi-asserted-by":"publisher","first-page":"e0057","DOI":"10.2106\/JBJS.OA.18.00057","volume":"4","author":"S Tsukada","year":"2019","unstructured":"Tsukada S, Kurosaka K, Nishino M, Maeda T, Hirasawa N. A strategy of continued antiplatelet agents, vitamin K antagonists, and direct oral anticoagulants throughout the perioperative period of total knee arthroplasty in patients receiving chronic antithrombotic therapy. JBJS Open Access. 2019;4:e0057.","journal-title":"JBJS Open Access"},{"key":"2890_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2106\/JBJS.N.00373","volume":"97","author":"S Tsukada","year":"2015","unstructured":"Tsukada S, Wakui M, Hoshino A. Pain control after simultaneous bilateral total knee arthroplasty: a randomized controlled trial comparing periarticular injection and epidural analgesia. J Bone Joint Surg Am. 2015;97:367\u201373.","journal-title":"J Bone Joint Surg Am"},{"key":"2890_CR13","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s00167-018-5140-y","volume":"27","author":"S Tsukada","year":"2019","unstructured":"Tsukada S, Kurosaka K, Maeda T, Iida A, Nishino M, Hirasawa N. Early stage periarticular injection during total knee arthroplasty may provide a better postoperative pain relief than late-stage periarticular injection: a randomized-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2019;27:1124\u201331.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2890_CR14","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1016\/j.arth.2018.06.010","volume":"33","author":"S Tsukada","year":"2018","unstructured":"Tsukada S, Kurosaka K, Nishino M, Hirasawa N. Cutaneous Hypesthesia and kneeling ability after total knee arthroplasty: a randomized controlled trial comparing anterolateral and anteromedial skin incision. J Arthroplast. 2018;33:3174\u201380.","journal-title":"J Arthroplast"},{"key":"2890_CR15","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.arth.2017.03.011","volume":"32","author":"S Tsukada","year":"2017","unstructured":"Tsukada S, Fujii T, Wakui M. Impact of soft tissue imbalance on knee flexion angle after posterior stabilized total knee arthroplasty. J Arthroplast. 2017;32:2399\u2013403.","journal-title":"J Arthroplast"},{"key":"2890_CR16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa023153","volume":"349","author":"PS Wells","year":"2003","unstructured":"Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349:1227\u201335.","journal-title":"N Engl J Med"},{"key":"2890_CR17","first-page":"224","volume":"51","author":"SB Nadler","year":"1962","unstructured":"Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51:224\u201332.","journal-title":"Surgery"},{"key":"2890_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/bja\/aer274","volume":"107","author":"J Mantz","year":"2011","unstructured":"Mantz J, Samama CM, Tubach F, Devereaux PJ, Collet JP, Albaladejo P, Cholley B, Nizard R, Barr\u00e9 J, Piriou V, Poirier N, Mignon A, Schlumberger S, Longrois D, Aubrun F, Far\u00e8se ME, Ravaud P, Steg PG, Stratagem Study Group. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth. 2011;107:899\u2013910.","journal-title":"Br J Anaesth"},{"key":"2890_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.knee.2014.12.002","volume":"22","author":"F Karaaslan","year":"2015","unstructured":"Karaaslan F, Karao\u011flu S, Mermerkaya MU, Baktir A. Reducing blood loss in simultaneous bilateral total knee arthroplasty: combined intravenous-intra-articular tranexamic acid administration: a prospective randomized controlled trial. Knee. 2015;22:131\u20135.","journal-title":"Knee"},{"key":"2890_CR20","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1056\/NEJMsr1203730","volume":"367","author":"RJ Little","year":"2012","unstructured":"Little RJ, D\u2019Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, Neaton JD, Rotnitzky A, Scharfstein D, Shih WJ, Siegel JP, Stern H. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367:1355\u201360.","journal-title":"N Engl J Med"},{"key":"2890_CR21","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1016\/j.arth.2018.08.002","volume":"33","author":"YA Fillingham","year":"2018","unstructured":"Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Bini SA, Clarke HD, Schemitsch E, Johnson RL, Memtsoudis SG, Sayeed SA, Sah AP, Della Valle CJ. Tranexamic acid use in total joint arthroplasty: the clinical practice guidelines endorsed by the American Association of hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic surgeons, hip society, and knee society. J Arthroplast. 2018;33:3065\u20139.","journal-title":"J Arthroplast"},{"key":"2890_CR22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, The CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med. 1991;324:781\u20138.","journal-title":"N Engl J Med"},{"key":"2890_CR23","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","volume":"289","author":"RT Chlebowski","year":"2003","unstructured":"Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A, WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women\u2019s Health Initiative Randomized Trial. JAMA. 2003;289:3243\u201353.","journal-title":"JAMA"},{"key":"2890_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","volume":"376","author":"F Ismail-Beigi","year":"2010","unstructured":"Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I, ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419\u201330.","journal-title":"Lancet"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-2890-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-019-2890-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-2890-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:11:06Z","timestamp":1603235466000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-019-2890-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2890"],"URL":"https:\/\/doi.org\/10.1186\/s12891-019-2890-8","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"29 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the institutional review board of Hokusuikai Kinen Hospital. All patients provided written informed consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The publication of this study was approved by the institutional review board of Hokusuikai Kinen Hospital. All patients provided written informed consent to publish.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"464"}}